Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
1136
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
tocilizumab
100%
Adrenal Cortex Hormones
15%
Hypoxia
15%
Standard of Care
12%
Artificial Respiration
12%
Therapeutics
11%
Inflammation
11%
Oxygen
9%
National Institutes of Health (U.S.)
6%
Biomedical Research
6%
Intention
5%
C-Reactive Protein
5%
Air
5%
Odds Ratio
4%
Weights and Measures
4%
Survival
3%
Mortality
3%
Population
2%